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Abstract 
 
Background: Despite extensive knowledge on the functional, neurodevelopmental, 
behavioural, and educational sequelae of preterm birth, relatively little is known about its 
economic consequences. 
Objectives: To systematically review evidence around the economic consequences of preterm 
birth for the health services, for other sectors of the economy, for families and carers and, 
more broadly, for society. 
Methods: Updating previous reviews, systematic searches of Medline, EconLit, Web of 
Science, the Cochrane Library, CINAHL, Embase and SCOPUS were performed using broad 
search terms, covering the literature from 1st January 2009 to 28th June 2017. Studies 
reporting economic consequences, published in the English language and conducted in a 
developed country were included. Economic consequences are presented in a descriptive 
manner according to study time horizon, cost category, and differential denominators (live 
births or survivors). 
Results: Of 4,384 unique articles retrieved, 43 articles met the inclusion criteria. Of these, 27 
reported resource use or cost estimates associated with the initial period of hospitalisation, 
whilst 26 reported resource use or costs incurred following the initial hospital discharge, 10 of 
which also reported resource use or costs associated with the initial period of hospitalisation. 
Only two studies reported resource use or costs incurred throughout the childhood years. 
Initial hospitalisation costs varied between $576,972 (range of $111,152 to $576,972) per 
infant born at 24 weeks’ gestation to $930 (range of $930 to $7114) per infant born at term 
(US$, 2015 prices). The review also revealed a consistent inverse association between 
gestational age at birth and economic costs regardless of date of publication, country of 
publication, underpinning study design, follow-up period, age of assessment or costing 
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approach; and a paucity of evidence on non-healthcare costs. Several categories of economic 
costs, such as additional costs borne by families as a result of modifications to their everyday 
activities, are largely overlooked by this body of literature. Moreover, the number and 
coverage of economic assessments has not increased in comparison to previous review 
periods. 
Conclusion: Evidence identified by this review can be used to inform clinical and budgetary 
service planning and act as data inputs into future economic evaluations of preventive or 
treatment interventions. Future research should focus particularly on valuing the economic 
consequences of preterm birth in adulthood. 
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Introduction 
 
Preterm birth has been defined by the World Health Organisation (WHO) as any birth before 
37 completed weeks’ gestation, or fewer than 259 days since the first day of the mother’s last 
menstrual period.1  It has been further subdivided into subcategories based on gestational age 
at birth, including extremely preterm (<28 weeks’ gestation), very preterm (28-<32 weeks’ 
gestation), moderately preterm (32-<34 weeks’ gestation) and late preterm (34-<37 weeks’ 
gestation).2 Almost 15 million babies worldwide were born preterm in 2010, representing 
11.1% of all livebirths, with prevalence ranging from approximately 5% in several northern 
European countries to 18% in Malawi.2 Moreover, time trends based on data from 65 
countries with reliable time trend data between 1990 and 2010 and more than 10,000 live 
births per year reveal that the preterm birth rate has either remained stable (n=14) or increased 
(n=48) in 62 of those 65 countries.2 
     Mortality as a result of preterm birth complications ranks, together with pneumonia, as the 
leading cause of childhood deaths at the global level with over 3 million related annual 
neonatal deaths worldwide.3 Although survival rates have improved in recent years, this 
masks considerable variation in the chances of survival across4 and within5 countries. 
Furthermore, surviving children are at higher risk of cerebral palsy, visual and auditory 
deficits, poor respiratory outcomes, impaired motor and cognitive ability and psychiatric 
disorders than children born at term.6-9 Up to one third of children born extremely or very 
preterm and their parents face a life course with significant morbidity, dependency, and 
socioeconomic challenges.10 
     Despite an extensive body of knowledge on the functional, neurodevelopmental, 
behavioural, and educational sequelae of preterm birth,11 12 relatively little is known about its 
economic consequences. This paper presents a systematic review of the recent scientific 
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literature on the economic consequences of preterm birth for the health services, for other 
sectors of the economy, for families and carers and, more broadly, for society. The paper 
represents an update of previous review articles of the topic published by one of the authors 
(SP) that had covered the periods 1980-1999 and January 2000 to June 2009, respectively.13 14 
 
Methods 
 
The systematic review followed the preferred reporting items for systematic reviews and 
meta-analyses (PRISMA) guidelines.15 A comprehensive literature search strategy was 
developed and piloted, building upon our previous reviews of the topic.13 14 The final search 
strategy encompassed granulated thesauri terms and free text search terms associated with 
preterm birth (e.g. preterm or premature* or low birthweight or gestational age) intersected 
with terms associated with economic consequences (e.g. “cost*” or “economic burden*” or 
“financial burden*” or “resource expenditure*” or “health care cost*” or “cost of illness”), 
and is presented in full in Appendix 1. The time horizon of the search strategy covered the 
period between 1st January 2009 and 28th June 2017. The electronic databases searched 
included Medline, EconLit, Web of Science (including Index to Scientific and Technical 
Proceedings, Science Citation Index, Social Science Citation Index), the Cochrane Library 
(including York Database of Abstracts of Reviews of Effectiveness, NHS Economic 
Evaluation Database), CINAHL, Embase and SCOPUS. Our search strategy was 
supplemented by manual reference searching of bibliographies, contacts with experts in the 
field, citation searching and author searching. All articles identified by the searches were 
entered into EndNote v7.7 and duplicates removed. 
     The main inclusion criteria framing the search strategy were primary studies reporting 
economic consequences associated with preterm birth (<37 weeks’ gestation) or low 
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birthweight (<2500 g); published in the English language; and conducted in a developed 
country (defined, for the purposes of this review, as a member of the Organisation for 
Economic Co-operation and Development (OECD)). A two stage screening process was 
followed. Titles and abstracts were assessed at the first stage of the review by two 
independent reviewers (HHY and JK). If an article received approval from both reviewers, it 
proceeded to the next stage, with disagreements referred to a third reviewer (SP) for the final 
assessment. At the second stage, two reviewers (HHY and SP) independently reviewed full 
text articles to assess whether they met the review’s inclusion criteria, with disagreements 
resolved via consensus. The term ‘article’ is used in its broadest sense and encompasses 
monographs, book chapters and conference abstracts. Studies of the economic consequences 
of low birth weight were included at the second stage of the review in order to capture 
potentially relevant information from contexts of clinical uncertainty in and incomplete 
recording of estimates of gestation. In addition, studies that reported the resource 
consequences associated with preterm birth or low birthweight in metrics amenable to future 
economic analyses were included at the second stage of the review for completeness. We 
excluded studies at the full article stage that: (i) were not relevant to economic aspects of 
preterm birth or low birthweight; (ii) did not report primary research evidence; (iii) were not 
published in the English language; (iv) treated preterm birth or low birthweight as a covariate 
rather than as a dependent variable or outcome; or (v) provided insufficient information to 
arrive at an economic assessment. 
     From each article that met the study selection criteria, we extracted the following 
information about the characteristics of the study using a bespoke proforma and entered it into 
an excel database: (i) bibliographic details, including year of publication; (ii) date of 
cohort/study; (iii) country/geographical jurisdiction; (iv) study design; (v) sample size(s); (vi) 
gestational age(s) at birth of study participants; (vii) birth weight(s) of study participants; 
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(viii) period over which study participants were followed up; (ix) cost categories; (x) resource 
use categories; (xi) currency in which costs were expressed; (xii) financial year for which 
costs were valued; and (xiii) cost data sources for the valuation process. The quality of 
contributing studies was assessed using a subset of 18 relevant items selected from the 24-
item CHEERS reporting checklist for health economic evaluations.16 Cost data extracted from 
studies was inflated, where necessary, to 2015 prices using the relevant country-specific 
Gross Domestic Product deflator index, and subsequently converted, where necessary, from 
their respective currencies into US dollars using purchasing power parities supplied by the 
OECD.17 For studies that failed to report their currency price dates, it was assumed that the 
costs used in the valuation process applied to the financial year prior to the publication of the 
study. 
     Methodological variations between studies, including variations in underpinning health 
care practices across jurisdictions and variations in the relative prices of labour and capital 
inputs across jurisdictions, prevented a pooling of economic data akin to the meta-analyses 
performed on clinical effectiveness estimates. Rather, resource use and economic cost 
estimates are presented in a descriptive manner according to study time horizon, resource use 
and/or cost category, and differential denominators (live births or survivors). 
 
Results 
 
A total of 4,384 unique articles were identified by the combined literature searches (Figure 1). 
Of these, only 107 articles satisfied the first stage inclusion criteria, whilst a further 64 articles 
were excluded at the second stage of the review process. A total of 43 articles met the 
inclusion criteria at both stages and were included in the systematic review.18-60 Of these 43 
articles, 27 reported resource use or cost estimates associated with the initial period of 
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hospitalisation,18-21 23-26 29 31 36-38 40 42-44 46-49 51 53 54 56 57 59 whilst 26 reported resource use or 
costs incurred following the initial hospital discharge,21-23 25 27 28 30 32-36 38-41 45-47 50 52 54-56 58 60 
10 of which also reported resource use or costs associated with the initial period of 
hospitalisation.21 23 25 36 38 40 46 47 54 56 Only two studies reported resource use or costs incurred 
throughout the childhood years.33 46 The quality of studies that met the inclusion criteria of the 
review is summarised in Appendix 2 with quality assessment scores ranging from 224 44 48 51 
and 17.35 40 57 Notable methodological limitations included a failure to specify price dates for 
cost estimates,18 21 23 34 43 44 47 48 51 failure to report discount rates for longer-terms costs,22 30 33 
34 50 54 55 58 and reliance on charges, which are likely to have included elements arising from 
corporate financial decisions.19 
     The methodological characteristics of studies reporting resource use and/or economic cost 
estimates associated with the initial hospitalisation, including their underpinning design, 
sample size, study population, study perspective and data sources are summarised in brief 
format in Table 1 and in full format in Appendix 3. Study estimates of hospital length of stay 
and economic costs are presented for differential denominators (live births or survivors) in 
brief format in Table 2 and in full format in Appendix 4. Initial hospitalisation costs varied 
between $576,97229 (range of $111,15257 to $576,97229) per infant born at 24 weeks’ 
gestation to $93043 (range of $93043 to $711459) per infant born at term, and from $169,132 
per surviving infant born at <1,500g51 to $1,200 per infant born at ≥2500g21 (US$, 2015 
prices). The duration of the initial hospitalisation varied between a median of 11631 days 
(range of a mean of 8453 to a median of 11631 days) per surviving infant born at 24 weeks’ 
gestation and a mean of 2.421 days (range of 2.421 to 5.242) per infant born at term. A 
consistent inverse association was observed between gestational age at birth and economic 
costs regardless of date of publication, country of publication, underpinning study design or 
costing approach. The only exceptions were three studies that showed that, amongst infants 
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born at ≤26 weeks’ gestation, costs increased as gestational age increased.44 57 59 The 
denominators for these analyses were live births and therefore included infants that died as 
well as those that survived; the implication is that initial hospitalisation costs increased with 
gestational age in these cohorts as a consequence of the improved survival chances of the 
least immature. Only two studies estimated maternal costs to understand additional resources 
that may be associated with preterm birth.29 47 Both studies revealed an inverse association 
between gestational age at birth and mean maternal costs. Moreover, only one study estimated 
non-healthcare costs associated with the initial period of hospitalisation.25 In a prospective 
cohort study of 150 very low birth weight (VLBW) infants without prematurity-related 
morbidities and 145 full-term controls, Cavallo et al. used parental questionnaires to estimate 
that travel costs borne by parents and the value of lost productivity represented 7.2% and 
29.6% of total societal costs, respectively, in the VLBW group, and 1.6% and 64.1% of total 
societal costs, respectively, in the control group.25 Another notable feature of economic 
studies that focussed on the initial hospitalisation is the observed independent effect of 
multiplicity on increased hospitalisation costs.43 57 
     The methodological characteristics of studies reporting resource use and/or economic costs 
following initial hospitalisation are summarised in Appendix 5 with study estimates of 
economic outcomes presented in Appendix 6. Ten studies estimated outcomes during the first 
two years of life21 23 25 28 36 41 45 47 56 60 with the remainder of studies estimating economic 
outcomes over longer follow-up periods or at later ages within cross-sectional studies. A 
consistent inverse association was observed between gestational age at birth and economic 
costs regardless of period of follow-up and age at assessment. This pattern held when children 
born moderate or late preterm were compared to children born at term,22 23 27 30 36 41 47 55 60 and 
when children born at early term were compared to children born at late term.30 41 55 60 
Longitudinal studies with assessments of economic outcomes at repeated time points revealed 
10 
 
that health service resource use and costs declined as children aged, regardless of gestational 
age at birth.27 30 38 50 54 Eight studies estimated economic costs accruing post initial discharge, 
associated with preterm birth, which are borne outside of the health sector.25 30 35 36 39 46 47 52 
Non-health service costs exceeded health service costs in the studies by Cavallo et al,25 which 
was limited to an 18 month time horizon, and the study by Petrou et al,52 which was limited to 
the 11th year of life, although no study valued economic costs borne by all sectors of the 
economy and by caregivers. 
     The two studies that reported economic costs throughout the childhood years used 
different methodological approaches. The earlier study, by Mangham et al,46 applied decision-
analytic modelling to estimate public sector costs associated with preterm birth. The model 
assumed a hypothetical cohort of children, equivalent in size to the number of live births in 
England and Wales in 2006, and was populated using data from thee cohort studies, namely 
EPICure, the Victorian Infant Collaborative Study, and the Oxford Record Linkage Study. 
The mean incremental public sector cost per preterm child surviving to 18 years, compared 
with a term survivor, was estimated at $39,329 (US$, 2015 prices). The corresponding 
estimates for a very and extremely preterm child were substantially higher at $106,174 and 
$162,816, respectively. More recently, Hummer et al33 applied econometric methods to 
Austrian health insurance administrative panel data linked to birth registry data. They found 
that although absolute differences in health service utilisation between children with 
birthweights <2500g and ≥2500g diminished over time, those born at low birthweight still 
spent significantly more days in hospital and generated significantly higher medical drug and 
medical assistance expenses through early childhood. Furthermore, there was a shift during 
the years of compulsory schooling towards care for diseases of the nervous system and mental 
and behavioural disorders among children born at low birthweight with effects persisting until 
early adulthood. 
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Discussion 
 
This paper systematically reviews the recent (2009-2017) scientific literature on the economic 
consequences of preterm birth for alternative stakeholders, updating two previous review 
articles of the topic.13 14 The number of relevant studies identified by this review was smaller 
than the number of studies covered by the most recent review (43 vs 52), which covered a 
comparable time horizon, although the number of countries in which studies were conducted 
increased (13 vs 6).14 In addition, a smaller proportion of studies estimated economic 
consequences following the initial hospital discharge (60.5% vs 67.3%) and economic 
consequences outside the health sector (18.6% vs 25.0%).14 There does not appear to be 
evidence that the increased longevity of cohort studies of children born preterm or the 
establishment of collaborative research platforms around preterm birth (e.g. http://www.apic-
preterm.org/) has increased the number or coverage of economic assessments. 
     When viewed in conjunction with evidence from previous systematic reviews,13 14 the 
economic costs to the health services, other sectors of the economy and to families and 
caregivers associated with preterm birth remain considerable. Comparisons of cost estimates 
with those reported for other childhood conditions are constrained by a number of 
methodological factors, including differences in costing methodologies, ages at assessment, 
study perspectives and periods of follow-up, as well variations in underpinning health care 
practices and relative prices of resource inputs across study settings. Nevertheless, a holistic 
overview of the identified evidence suggests that ongoing economic costs associated with 
extremely preterm and very preterm birth exceed the annual cost burdens reported for several 
chronic childhood conditions, including asthma,61 juvenile idiopathic arthritis,62 depression,63 
separation anxiety64 and attention-deficit hyperactivity disorder.65 
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     Several categories of economic costs have, with a few exceptions,36 52 been overlooked by 
this body of literature. These includes costs borne by local authorities and voluntary 
organisations, such as adaptations that have to be made to the individual’s home as a result of 
their impaired state of health, and additional costs borne by families as a result of 
modifications to their everyday activities. In addition to the costs of travel, child care and 
accommodation, other potential costs faced by families and informal carers that have been 
largely overlooked include incremental expenditures on health goods, such as alternative 
therapies, and non-health goods, such as nutritional requirements, laundry, clothing, heating 
utilities and repairs to the home. Methods for ascertaining these costs, including 
questionnaires, diaries and data extraction from administrative databases, are available and 
widely applied in other areas of health care.66 The value of ascertaining these costs should be 
balanced against the additional burden it may impose on study participants. 
     The full effects of impairment associated with preterm birth on economic outcomes 
clarifies only with time. Cohort studies with follow-up into adulthood and whole-country 
record linkage studies provide potential vehicles for ascertaining long-term economic 
outcomes such as long-term use of health and social care services, employment and 
occupational status, income, receipt of social welfare benefits and reproductive health, which 
might in turn have economic sequelae. As yet, no study has valued these long-term economic 
sequelae in adulthood. Recently established collaborative research platforms with a focus on 
outcomes in adulthood, such as the ‘Adults Born Preterm International Collaboration’ 
(http://www.apic-preterm.org/) and the ‘Research on European Children and Adults born 
Preterm’ programme (https://recap-preterm.eu/) should provide opportunities for economic 
research. 
     The strengths of this study are that it was conducted according to internationally agreed 
design and reporting guidelines for systematic reviews of economic evidence,67 and was 
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broadly consistent in its methodology with previous reviews of the topic, thereby allowing 
inter-temporal comparisons to be made.13 14 Limitations include exclusion of health utility-
based measures of economic outcome that can be used to inform cost-effectiveness based 
decision-making.68 It is likely that preterm birth is also associated with decrements in health 
utilities, i.e. preference-based health-related quality of life outcomes,69 which have not been 
assessed in this review. Furthermore, the review did not extend to an assessment of the cost-
effectiveness of preventive or treatment interventions for preterm birth. 
     The data identified by this review can be used to inform clinical and budgetary service 
planning and provide policy-relevant information for cross-country, longitudinal, and other 
cost comparisons.70 The data can also act as inputs within cost-effectiveness models for 
preventive or treatment interventions. There are several circumstances, particularly in the 
context of decision-analytic modelling-based economic evaluations, where economic analysts 
lack the time and resources to collect primary data for economic parameters of interest. This 
review has generated a body of data that can act as inputs into future economic models, and 
allows the reader to assess the suitability of the evidence for their particular context. 
     In conclusion, this paper presents a systematic review of the recent scientific literature on 
the economic consequences of preterm birth for the health services, for other sectors of the 
economy, for families and carers and, more broadly, for society. Future research should focus 
particularly on valuing the economic consequences of preterm birth in adulthood. 
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What is already known on this topic 
 There is extensive knowledge on the functional, neurodevelopmental, behavioural, and 
educational sequelae of preterm birth. 
 Evidence on the economic consequences of preterm birth is more limited with previous 
reviews of the topic extending only to 2009. 
 
What this study adds 
 This systematic review of the 2009-2017 literature on the economic consequences of 
preterm birth reveals no evidence that the increased longevity of cohort studies of 
children born preterm or the establishment of collaborative research platforms around 
preterm birth has increased the number or coverage of economic assessments. 
 The review reveals a consistent inverse association between gestational age at birth and 
economic costs regardless of date of publication, country of publication, underpinning 
study design, follow-up period, age of assessment or costing approach; and a continuing 
paucity of evidence on non-healthcare costs. 
 Evidence identified by this review can be used to inform clinical and budgetary service 
planning and act as data inputs into future economic evaluations of preventive or 
treatment interventions. 
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Table 1: Studies reporting resource use and/or economic costs associated with the initial hospitalisation (full methodological characteristics presented in 
Appendix 3) 
Study Date of 
birth of 
study 
population 
Location Type of study Sample size Gestational 
age(s) (weeks) 
Birth weight 
(g) 
Allen et al18  2012-2015 USA Case series 23 weeks: 12 
24 weeks: 17 
25 weeks: 22 
23–25  <2,500 
Almond et 
al19  
1983-2002 
 
1991-2006 
 USA  
 
5 US states 
(Arizona, 
California, 
Maryland, 
New Jersey, 
and New 
York) 
Retrospective analysis of 
national  birth cohort  
State inpatient research 
database analysis 
>200,000 newborns of three ounces around 
the 1,500 g threshold in the nationwide data; 
Approximately 30,000 births in the same 
interval for the five-state sample. 
NA  3 ounces (85g) 
bandwith from 
1,500g 
threshold 
Aly et al20   2007-2008 
 
USA Retrospective analysis of 
national  birth cohort  
All: 81,913  
33–34 weeks: 24,086 
35–36 weeks: 57,827 
33-34  
35-36  
NA 
Barradas et 
al21  
2009 USA Retrospective analysis of 
national  birth cohort  
4,167,000 (9.1% were preterm or low 
birthweight) 
<37 <2,500  
Bird et al23 2001-2005 USA 
(Arkansas) 
Retrospective analysis of 
Medicaid claims database 
34-36 weeks: 5188  
37-42 weeks: 15,303 
34-36   
37-42  
NA 
Bulut et al24  2006-2008 Turkey 
(Istanbul) 
Retrospective chart analysis 34-36 weeks: 6742  
≥37: 30,055 
 
34-36  
≥37 
 
NA 
Cavallo et 
al25  
2006 Italy Prospective cohort study ≤30 weeks and/or ≤1,500g: 150  
37-42 weeks: 145 
≤ 30  
37-42  
≤1,500 
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Comert et 
al26  
2006-2007 Turkey 
(Istanbul) 
Retrospective chart analysis 28-32 weeks: 96  
33-37 weeks: 115 
28-32  
33-37  
NA 
Hall and 
Greenberg29 
2012 USA 
(Hamilton 
County, 
Ohio) 
Retrospective chart analysis 10,976 births of which 1444 were preterm 23-27  
28-31  
32-36  
NA 
Hinchliffe et 
al31  
2006-2010 UK  
(East 
Midlands and 
Yorkshire) 
Population-based audit of 
neonatal care 
24 weeks: 296  
25 weeks: 384  
26 weeks: 551  
27 weeks: 663 
28 weeks: 829 
24-28  NA 
Khan et al36  2009-2010 UK  
(East 
Midlands) 
Prospective cohort study 32-33 : 162 
34-36: 984 
32-36 weeks: 1146  
≥37 weeks: 1258 
32-33  
34-36 
32-36  
≥37  
NA 
Khashu et 
al37  
1999-2002 Canada 
(British 
Columbia) 
Retrospective analysis of 
regional birth cohort  
33–36 weeks: 6381  
37–40 weeks: 88,867 
33–36  
37–40  
NA 
Korvenranta 
et al38  
2000-2003 Finland Retrospective national 
register study 
22-23 weeks: 17  
24-25 weeks: 135  
26-27 weeks: 234  
28-29 weeks: 391  
30-31 weeks: 771  
>31 weeks: 248 
<32  
  
<1501 
28 
 
Korvenranta 
et al40  
2000-2003 Finland Retrospective national 
register study 
Preterm survivors:  
23 weeks: 17   
24-25 weeks: 135  
26-27 weeks: 231  
28-29 weeks: 385  
30-31 weeks: 756 
Preterm non-survivors: 278  
Term: 200,609 
<32  
37–41 
 
<1501 
Leone et al42  2006-2007 Switzerland Retrospective chart analysis 34-36 weeks: 530 
39-40 weeks: 1686 
34-36  
39-40 
NA 
Lim et al43  2005-2006 Canada Retrospective national 
register study 
Singletons:  
<28 weeks: 762 
28-31 weeks: 1099  
32-33 weeks: 1428 
34-36 weeks: 9716  
≥37 weeks: 189,750  
Multiples:  
<28 weeks: 264 
28-31 weeks: 418  
32-33 weeks: 571 
34-36 weeks: 2370  
≥37 weeks: 2742 
<28 
28-31  
32-33  
34-36 
≥37  
NA 
Lo et al44  2000-2008 USA Retrospective chart analysis Singleton deliveries: 240,179  24-42  NA 
Mangham et 
al46  
2006 England and 
Wales 
Decision-analytic model 
populated with data from 
administrative population-
based databases 
≤ 27 weeks: 3185 
28-31 weeks: 5575 
32-33 weeks: 6410 
34-36 weeks: 32,812 
≥37 weeks: 621,618 
All NA 
McLaurin et 
al47  
2004 USA Retrospective analysis of 
insurance database 
33-36 weeks: 1683  
≥37 weeks: 33,745 
33–36 
≥37 
NA 
Meyers and 
Meyers48 
2008 USA Retrospective analysis of 
national  birth cohort 
Not specified All All 
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Mistry et al49  2001-2002 UK (Basildon, 
Colchester and 
Southend in 
Essex and 
Gillingham in 
Kent) 
Prospective cohort study Three level 2 neonatal units: 192  
One level 3 neonatal unit: 199 
NA ≤1,800  
Nordermoen 
and Bratlid51 
1997-2007 Norway Retrospective analysis of 
two birth cohorts 
Not specified <28 weeks 
≥28 weeks 
<1500g 
Seaton et al53  2011-2014 England Retrospective analysis of 
electronic health records 
2011: 5368  
2012: 5343  
2013: 5228  
2014: 5099 
24-31  NA 
Stephens et 
al54  
2001-2011 Australia 
(New South 
Wales) 
Retrospective analysis of 
regional birth cohort 
24-27 weeks: 3659 
28-31 weeks: 7235 
32-33 weeks: 9007 
39-40 weeks: 539,631 
24-27  
28-31  
32-33  
39-40  
NA 
Thanh et al56  2004-2010 Canada 
(Alberta) 
Retrospective analysis of 
regional birth cohort 
<2,500g: 16,209 
≥2,500g: 189,586 
NA <2,500g 
≥2,500g 
van Baaren 
et al57  
2006-2012 Netherlands Retrospective analysis of 
one prospective cohort 
study and three randomised 
controlled trials 
4,552  
1090 singletons 
3462 multiples 
24–28  
28–32  
32–36 
≥37 
NA 
Xu et al59  2003 USA 
(Michigan) 
Retrospective analysis of 
regional birth cohort 
<37 weeks: 9780  
≥37 weeks: 101,484  
≥20  NA 
NA, not applicable. 
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Table 2: Summary of economic consequences associated with the initial hospitalisation (full results presented in Appendix 4) 
 
Study Date of 
birth of 
study 
population 
Unit of analysis Summary economic results 
Allen et al18  2012-2015 Mean cost per survivor  
(US$, 2016 prices)± 
23 weeks: 266,000±25,700 
24 weeks: 239,900±34,450 
25 weeks: 208,550±54,550 
Almond et al19  1983-2002 
  
Mean cost per live birth 
(US$, 2006 prices) 
(1US$2006=1.16US$2015) 
94,000 for the three ounces prior to the 1500g threshold, falling to 85,000 at three ounces 
after the threshold 
Aly et al20   2007-2008 
 
Mean length of stay per live 
birth (days) 
33-34 weeks: 10.7% ≤3 days; 89.3% > 3 days 
35-36 weeks: 56.0% ≤3 days; 44.0% > 3 days 
33-36 weeks: 42.7% ≤3 days; 57.3% > 3 days 
Barradas et al21  2009 Mean cost per live birth 
(US$, 2015 prices)± 
Medicaid (Med); Commercial (Com); Self-pay (SP) 
Preterm, low birthweight: 16,200; 15,300; 8,000 
<1500g: 57,000; 61,100; 24,000 
1,500–2,499g: 12,300; 12,600; 8,200 
>2,500g: 4600; 4,500; 3300 
No stated birthweight: 11,000; 10,300; 2600 
Term and normal birthweight: 1300; 1300; 1200 
Bird et al23 2001-2005 Mean length of stay per live 
birth (days) 
34-36 weeks: 2.61   
37-42 weeks: 1.96 
Bulut et al24  2006-2008 Mean length of stay per live 
birth (days) 
34-36 weeks: 7 
≥37 weeks: 4 
Cavallo et al25  2006 Mean cost per live birth  
(€, 2008 prices) 
(1€$2008=1.45US$2015) 
Hospital: ≤30 weeks and/or ≤1500g: 20,502; Term: 907 
Societal: ≤30 weeks and/or ≤1500g: 32,460; Term: 2640 
Comert et al26  2006-2007 Mean cost per live birth 
(US$, 2011 prices) ± 
(1US$2011=1.06US$2015) 
28-32 weeks: 2575;  
33-37 weeks: 1525 
Hall and 
Greenberg29 
2012 Mean cost per live birth 
(US$, 2012 prices) 
(1US$2012=1.04US$2015) 
23 weeks: 599,000; 24 weeks: 553,000; 25 weeks: 507,000; 26 weeks: 413,000; 27 weeks: 
347,000; 28 weeks: 277,000; 29 weeks: 216,000; 30 weeks: 172,000; 31 weeks: 123,000; 32 
weeks: 85,000; 33 weeks: 55,000; 34 weeks: 19,000; 35 weeks: 11,000; 36 weeks: 6000 
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Hinchliffe et 
al31  
2006-2010 Median length of stay per 
survivor (days) 
24 weeks: 116 
25 weeks: 107 
26 weeks: 93 
27 weeks: 76 
28 weeks: 65 
Khan et al36  2009-2010 Mean cost per live birth  
(£, 2010-11 prices) 
(1£2011=1.51US$2015) 
32-33 weeks: Postnatal: 2207.13; Neonatal: 9226.81; Transfer: 61.64; Post-mortem: 22.97; 
Surgery: 51.34; Investigations: 58.72; Other: 194.66; Total: 11,628.60 
34-36 weeks: Postnatal: 1948.73; Neonatal: 2497.97; Transfer: 12.24; Post-mortem: 2.52; 
Surgery: 46.13; Investigations: 20.5; Other: 81.40; Total: 4528.02 
32-36 weeks: Postnatal: 1985.26; Neonatal: 3449.17; Transfer: 19.23; Post-mortem: 5.41; 
Surgery: 46.86; Investigations: 25.91; Other: 97.41; Total: 5532.62 
≥37 weeks: Postnatal: 1708.54; Neonatal: 146.45; Transfer: 0.02; Post-mortem: 1.86; 
Surgery: 0.81; Investigations: 6.76; Other: 9.45; Total: 1864.38 
Khashu et al37  1999-2002 Mean length of stay per live 
birth (days) 
33-36 weeks: 5.92 
37-40 weeks: 2.38 
Korvenranta et 
al38  
2000-2003 Mean length of stay per 
survivor (days) 
22-23 weeks: 136.7; 24-25 weeks: 122.1; 26-27 weeks: 93.7; 28-29 weeks: 67.4; 30-31 
weeks: 47.6; >31 weeks: 42.3 
Korvenranta et 
al40  
2000-2003 Mean cost per survivor  
(€, 2008 prices) 
(1€$2008=1.23US$2015) 
23 (weeks): 147,398; 24-25 (weeks): 120,179; 26-27 (weeks): 88,188; 28-29 (weeks): 
56,588; 30-31 (weeks): 35,147; All preterm: 54,104; Term: 1334 
Leone et al42  2006-2007 Mean length of stay per live 
birth (days) 
34 weeks: 13.6; 35 weeks: 12.1; 36 weeks: 7.0; Term: 5.2 
Lim et al43  2005-2006 Mean cost per live birth 
(Can$, 2008 prices) ± 
(1Can$2008=0.89US$2015) 
Singletons:  
<28 weeks: 84,235 (singletons); 90,123 (multiples) 
28-31 weeks: 43,718 (singletons); 47,318 (multiples) 
32-33 weeks: 19,463 (singletons; 21,388 (multiples) 
34-36 weeks: 5047 (singletons); 6494 (multiples) 
Any preterm: 9233 (singletons); 12,479 (multiples) 
≥37 weeks: 1050 (singletons); 1871 (multiples) 
Lo et al44  2000-2008 Mean cost per live birth 
(US$, 2010 prices) ± 
(1US$2010=1.08US$2015) 
24 weeks: 98,162; 25 weeks: 83,070; 26 weeks: 90,936; 27 weeks: 79,463; 28 weeks: 59,928; 
29 weeks: 52,998; 30 weeks: 40,568; 31 weeks: 30,853; 32 weeks: 22,612; 33 weeks: 16,597; 
34 weeks: 9740; 35 weeks: 5015; 36 weeks: 2413; 37 weeks: 1469; 38 weeks: 1070; 39 
weeks: 994; 40 weeks: 1017; 41 weeks: 1058; 42 weeks: 1072       
Mangham et 
al46  
2006 Mean cost per survivor  
(£, 2006 prices) 
(1£2006=1.72US$2015) 
<28 weeks: Delivery: 1762; Neonatal: 84,453 
<33 weeks: Delivery: 708; Neonatal: 57,726 
<37 weeks: Delivery: 322; Neonatal: 21,066 
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McLaurin et 
al47  
2004 Mean cost per live birth 
(US$, 2008 prices)± 
(1US$2008=1.11US$2015) 
33-36 weeks: 26,054 
≥37 weeks: 2087 
Meyers and 
Meyers48 
2008 Mean cost per live birth 
(US$, 2010 prices)± 
(1US$2010=1.08US$2015) 
<2500g: 23,382 
≥2500g: 5951 
Mistry et al49  2001-2002 Mean cost per live birth  
(£, 2005-6 prices) 
(1£2006=1.72US$2015) 
Excluding ambulance transfer costs: Level 2 units: 12,344; Level 3 unit: 17,861 
Including ambulance transfer costs: Level 2 units: 12,881; Level 3 unit: 18,459 
Nordermoen 
and Bratlid51 
1997-2007 Mean cost per live 
birth/survivor  
(€, 2008 prices)± 
(1€$2008=1.30US$2015) 
<1500g: 1997: 67,700; 2007: 75.300/ 
<1500g: 1997: 130,100; 2007: 108,500 
<28 weeks: 1997: 349,000; 2007: 429,500 
Seaton et al53  2011-2014 Mean length of stay per live 
birth (days) 
Intensive care: 24 weeks: 33; 25 weeks: 30; 26 weeks: 23; 27 weeks: 18; 28 weeks: 14; 29 
weeks: 10; 30 weeks: 6; 31 weeks: 4 
High dependency: 24 weeks: 29; 25 weeks: 33; 26 weeks: 29; 27 weeks: 25; 28 weeks: 19; 29 
weeks: 13; 30 weeks: 9; 31 weeks: 6 
Special care: 24 weeks: 22; 25 weeks: 27; 26 weeks: 30; 27 weeks: 31; 28 weeks: 33; 29 
weeks: 33; 30 weeks: 31; 31 weeks: 28 
Stephens et al54  2001-2011 Median cost per live birth 
(US$, 2014 prices) 
(1US$2014=1.01US$2015) 
24-27 weeks: 180,515 
28-31 weeks: 62,450 
32-33 weeks: 23,455 
39-40 weeks: 2995 
Thanh et al56  2004-2010 Mean cost per live birth 
(Can$, 2013 prices) 
(1Can$2013=0.83US$2015) 
<2500g: 18,126 
≥2500g: 1657 
van Baaren et 
al57  
2006-2012 Mean cost per live birth  
(€, 2011 prices) 
(1€$2011=1.26US$2015) 
<24 weeks: Singletons: NA; multiples: 41,700; 24 weeks: Singletons: 88,052; multiples: 
79,572; 25 weeks: Singletons: 83,774; multiples:141,598; 26 weeks: Singletons: 71,821; 
multiples: 169,100; 27 weeks: Singletons: 70,984; multiples: 169,571; 28 weeks: Singletons: 
60,783; multiples: 135,084; 29 weeks: Singletons: 45,444; multiples: 102,048; 30 weeks: 
Singletons: 34,510; multiples: 66,013; 31 weeks: Singletons: 26,296; multiples: 44,405; 32 
weeks: Singletons: 21,157; multiples: 33,991; 33 weeks: Singletons: 15,912; multiples: 
30,129; 34 weeks: Singletons: 11,222; multiples: 21,457; 
35 weeks: Singletons: 6492; multiples: 14,306; 36 weeks: Singletons: 2924; multiples: 8618; 
≥37 weeks: Singletons: 1434; multiples: 5201 
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Xu et al59  2003 Mean cost per live birth 
(US$, 2007 prices) 
(1US$2007=1.13US$2015) 
20 weeks: 11,397; 21 weeks: 11,703; 22 weeks: 25,367; 23 weeks: 48,908; 24 weeks: 
99,477; 25 weeks: 82,296; 26 weeks: 103,980; 27 weeks: 72,212; 28 weeks: 56,933; 29 
weeks: 45,598; 30 weeks: 34,642; 31 weeks: 29,679; 32 weeks: 24,623; 33 weeks: 21,887; 
34 weeks: 18,617; 35 weeks: 15,864; 36 weeks: 12,305; ≥37 weeks: 6368 
± As currency price dates not reported, it was assumed that the costs used in the valuation process applied to the financial year prior to study 
publication.  
 Cost conversion rates reflecting relevant country-specific Gross Domestic Product deflator indices and purchasing power parities supplied by the 
OECD. These rates vary across individual countries using the same currency such as the €.17 
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Figure 1: PRISMA Flow Diagram 
5retertt 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 PRISMA denotes preferred reporting items for systematic reviews and meta-analyses. 
 
  
Articles identified through 
literature searching  
(N = 8,156) 
Removal of duplicate records  
(N = 3,772) 
Articles screened at the first stage: The title and 
abstract screening stage  
(N = 4,384) 
Articles excluded  
(N = 4,277) 
Articles screened at the second stage: Full-text 
articles assessed for eligibility  
(N = 107) 
Full-text articles excluded, with 
reasons (N = 64)  
1) Article was not relevant to 
economic aspects of preterm 
birth of low birthweight (N= 
11) 
2) Secondary research with no 
primary research evidence 
(e.g. a review article) (N= 9) 
3) Full articles was not 
published in the English 
language (N=1) 
4) Preterm birth of low 
birthweight was treated as a 
covariate and not the primary 
focus of the analysis (N=32) 
5) Other reasons (N=11) 
 
 
 
  
Articles included in 
final review  
(N = 43) 
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Appendix 1: Literature search strategy 
Search terms: 
 
“gestational age” OR “low birthweight” OR “low birth weight” OR “low-birthweight” OR “low- birth-
weight” OR “low-birth weight” OR ((pre-term OR preterm OR “pre term” OR prematur* OR early) 𝛑 
(birth OR delivery OR parturition OR labour OR labor OR "labour onset" OR "labor onset")) 
 
AND 
 
“cost*” OR “economic burden*” OR “financial burden*” OR “resource expenditure*” OR “health care 
cost*” OR “cost of illness” OR “costs and cost analys?s” OR “health expenditure*” OR “economic 
cost*” OR “economic analys?s” OR “economic consequence*” OR “economic implication*” OR “cost 
saving*” OR “medical expenditure*” OR “medical cost*” OR “healthcare expenditure*” OR “health 
care expenditure*” OR “healthcare cost*” OR “health care cost*” OR “cost allocation” OR “direct 
service cost*” OR “drug cost*” OR “employer health cost*” OR “hospital cost*” OR “capital 
expenditure*” OR “direct cost*” OR “indirect cost*” OR “intangible cost*”.  
 
Search engines: Medline, EconLit, Web of Science (including Index to Scientific and Technical 
Proceedings, Science Citation Index, Social Science Citation Index), the Cochrane Library (including 
York Database of Abstracts of Reviews of Effectiveness, NHS Economic Evaluation Database), 
CINAHL, Embase and SCOPUS. 
 
Note: Medline, Embase and CINAHL required the incorporation of MeSH (Medical Subject Headings) 
terms during the literature search process. The MeSH terms of these three databases are summarised as 
follows:  
Medline: “health expenditures”, “costs and cost analysis” OR “cost of illness” OR “health care costs”, 
"economics, hospital" AND "economics, medical", “cost saving”, “cost allocation”; Embase:  "cost" OR 
"drug cost" OR "hospital running cost" OR "hospital cost" OR "cost of illness" OR "hospitalization cost", 
"health care cost";  
CINAHL:  "health care costs" OR "costs and cost analysis" OR "health facility costs" OR "cost savings" 
OR "economic aspects of illness". 
 
 Also, 
𝛑 = {
adjn,                                                 for Medline
Nn,     for Embase, EconLit and CINAHL   
w n⁄ ,                                                     for Scopus
NEAR n⁄ , for Web of Science, Cochrane Library
 
 
where 𝑛 = the specified gap in number of words. Under the consideration of the above search terms, 𝑛 
was set to 3.  
 
Time horizon: 1st January 2009 to 28th June 2017. 
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Appendix 2: Reporting quality assessment results according to a subset of the Consolidated Health 
Economic Evaluation Reporting Standards (CHEERS) reporting items 
Studies only reporting resource utilisation 
Study Reporting quality score (out of maximum 16) 
Aly et al20 14 
Corchia et al27 14 
Hinchliffe et al31 13 
Hong et al32 13 
Khashu et al37 13 
Korvenranta et al38  14 
Kuzniewicz et al41 12 
Leone et al42 12 
Luu et al45 13 
Seaton et al53 14 
Young et al60 13 
Mean score 13.18 
 
Studies reporting economic costs  
Study Reporting quality score (out of maximum 18) 
Allen et al18 12 
Almond et al19 15 
Barradas et al21 12 
Berard et al22 16 
Bird et al23 13 
Bulut et al24 2 
Cavallo et al25 16 
Comert et al26 13 
Gareau et al28 14 
Hall and Greenberg29 16 
Helle et al30 16 
Hummer et al33 13 
Jacob et al34 13 
Johnston et al35  17 
Khan et al36 16 
Korvenranta et al39  16 
Korvenranta et al40 17 
Lim et al43 12 
Lo et al44 2 
Mangham et al46  16 
McLaurin et al47 14 
Meyers and Meyers48 2 
Mistry et al49 14 
Mourani et al50 15 
Nordermoen and Bratlid51 2 
Petrou et al52 14 
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Stephens et al54 16 
Stephens et al55 15 
Thanh et al56 15 
van Baaren et al57  17 
Westrupp et al58 16 
Xu et al59 14 
Mean score 13.16 
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Appendix 3: Full methodological characteristics of studies reporting resource use and/or economic costs associated with the initial hospitalisation 
Study Date of 
birth of 
study 
populat
ion 
Location Type of study Sample size Gestational 
age(s) 
(weeks) 
Birth weight 
(g) 
Type of 
resource 
inputs/costs 
Data sources 
Allen et al18  2012-
2015 
USA Case series 23 weeks: 12 
24 weeks: 17 
25 weeks: 22 
23–25  <2,500 Hospital A single tertiary care, university-
based NICU over 42 months 
Almond et 
al19  
1983-
2002 
  
1991-
2006 
USA,  
 
 
 
 
5 US states 
(Arizona, 
California, 
Maryland, 
New Jersey, 
and New 
York) 
Retrospective 
analysis of 
national  birth 
cohort  
 
State inpatient 
research 
database 
analysis 
>200,000 newborns 
of three ounces 
around the 1,500 g 
threshold in the 
nationwide data; 
Approximately 
30,000 births in the 
same interval for the 
five-state sample. 
NA  3 ounces 
(85g) 
bandwith 
from 1,500g 
threshold 
Hospital 
(charges) 
(i) Census of U.S. births with 
linked death and hospital 
discharge data; (ii) State-wide 
births linked to death and hospital 
discharge data. 
 
Aly et al20   2007-
2008 
 
USA Retrospective 
analysis of 
national  birth 
cohort  
All: 81,913  
33–34 weeks: 24,086, 
35–36 weeks: 57,827 
33-34  
35-36  
NA Hospital US Nationwide Inpatient Sample 
Database 
Barradas et 
al21  
2009 USA Retrospective 
analysis of 
national  birth 
cohort  
4,167,000 (9.1% 
were preterm or low 
birthweight) 
<37 <2,500  Hospital US Nationwide Inpatient Sample 
Database  
Bird et al23 2001-
2005 
USA 
(Arkansas) 
Retrospective 
analysis of 
Medicaid 
34-36 weeks: 5188  
37-42 weeks: 15,303 
34-36   
37-42  
NA Hospital Arkansas Medicaid claims data 
linked to state birth certificate 
data  
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claims 
database 
Bulut et al24  2006-
2008 
Turkey 
(Istanbul) 
Retrospective 
chart analysis 
34-36 weeks: 6742  
≥37: 30,055 
 
34-36  
≥37 
 
NA Hospital Zeynep Kamil Maternity and 
Childrens’ Disease Training and 
Research State Hospital 
Cavallo et 
al25  
2006 Italy Prospective 
cohort study 
≤30 weeks and/or 
≤1,500g: 150  
37-42 weeks: 145 
≤ 30  
37-42  
≤1,500 Hospital and 
broader 
societal 
Prospective data collection in 25 
neonatal intensive care units and 
from parent hospitals for controls. 
Parental questionnaires. 
Comert et 
al26  
2006-
2007 
Turkey 
(Istanbul) 
Retrospective 
chart analysis 
28-32 weeks: 96  
33-37 weeks: 115 
28-32  
33-37  
NA Hospital Dr. L. Kırdar Kartal Research and 
Training Hospital NICU 
Hall and 
Greenberg29 
2012 USA 
(Hamilton 
County, 
Ohio) 
Retrospective 
chart analysis 
10,976 births of 
which 1444 were 
preterm 
23-27  
28-31  
32-36  
NA Hospital Ohio Department of Health 
Hinchliffe et 
al31  
2006-
2010 
UK  
(East 
Midlands 
and 
Yorkshire) 
Population-
based audit of 
neonatal care 
24 weeks: 296  
25 weeks: 384  
26 weeks: 551  
27 weeks: 663 
28 weeks: 829 
24-28  NA Hospital 
(neonatal 
care) 
The Neonatal Survey: A 
population-based audit of 
inpatient neonatal care 
Khan et al36  2009-
2010 
UK  
(East 
Midlands) 
Prospective 
cohort study 
32-33 : 162 
34-36: 984 
32-36 weeks: 1146  
≥37 weeks: 1258 
32-33  
34-36 
32-36  
≥37  
NA Postnatal, 
neonatal, 
transfers, 
post-mortems, 
surgery, 
investigations. 
Bespoke questionnaires designed 
for The Late and Moderate 
Preterm Birth Study (LAMBS) 
Khashu et 
al37  
1999-
2002 
Canada 
(British 
Columbia) 
Retrospective 
analysis of 
regional birth 
cohort  
33–36 weeks: 6381  
37–40 weeks: 88,867 
33–36  
37–40  
NA Hospital British Columbia (BC) Perinatal 
Database Registry and Reporting 
Tool of the BC Reproductive Care 
Program 
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Korvenranta 
et al38  
2000-
2003 
Finland Retrospective 
national 
register study 
22-23 weeks: 17  
24-25 weeks: 135  
26-27 weeks: 234  
28-29 weeks: 391  
30-31 weeks: 771  
>31 weeks: 248 
<32  
  
<1501 Hospital Finnish Medical Birth Register 
and Finnish Hospital Discharge 
Register 
Korvenranta 
et al40  
2000-
2003 
Finland Retrospective 
national 
register study 
Preterm survivors:  
23 weeks: 17   
24-25 weeks: 135  
26-27 weeks: 231  
28-29 weeks: 385  
30-31 weeks: 756 
Preterm non-
survivors: 278  
Term: 200,609 
<32  
37–41 
 
<1501 Hospital Finnish Medical Birth Register 
and Finnish Hospital Discharge 
Register 
Leone et al42  2006-
2007 
Switzerland Retrospective 
chart analysis 
34-36 weeks: 530 
39-40 weeks: 1686 
34-36  
39-40 
NA Hospital University Hospital of Zurich and 
its four surrounding hospitals: 
Zollikerberg, Triemli, Limmattal 
and Uster. 
Lim et al43  2005-
2006 
Canada Retrospective 
national 
register study 
Singletons:  
<28 weeks: 762 
28-31 weeks: 1099  
32-33 weeks: 1428 
34-36 weeks: 9716  
≥37 weeks: 189,750 
Multiples:  
<28 weeks: 264 
28-31 weeks: 418  
32-33 weeks: 571 
34-36 weeks: 2370  
≥37 weeks: 2742 
<28 
28-31  
32-33  
34-36 
≥37  
NA Hospital Discharge Abstract Database and 
Canadian Management 
Information Systems Database, 
Canadian Institute for Health 
Information 
Lo et al44  2000-
2008 
USA Retrospective 
chart analysis 
Singleton deliveries: 
240,179  
24-42  NA Hospital 18 hospitals within a single health 
care system 
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Mangham et 
al46  
2006 England 
and Wales 
Decision-
analytic model 
populated with 
data from 
administrative 
population-
based 
databases 
≤ 27 weeks: 3185 
28-31 weeks: 5575 
32-33 weeks: 6410 
34-36 weeks: 32,812 
≥37 weeks: 621,618 
All NA Delivery, 
neonatal 
Secondary data from external 
cohorts and cross-sectional 
studies 
McLaurin et 
al47  
2004 USA Retrospective 
analysis of 
insurance 
database 
33-36 weeks: 1683  
≥37 weeks: 33,745 
33–36 
≥37 
NA Hospital MedStat MarketScan Commercial 
Claims and Encounters database 
Meyers and 
Meyers48 
2008 USA Retrospective 
analysis of 
national  birth 
cohort 
Not specified All All Hospital 2008 Healthcare Cost and 
Utilization Project Nationwide 
Inpatient Sample 
Mistry et al49  2001-
2002 
UK 
(Basildon, 
Colchester 
and 
Southend in 
Essex and 
Gillingham in 
Kent) 
Prospective 
cohort study 
Three level 2 
neonatal units: 192  
One level 3 neonatal 
unit: 199 
NA ≤1,800  Neonatal 
care 
One regional level 3 unit and 
three level 2 units providing 
short-term intensive care 
Nordermoen 
and Bratlid51 
1997-
2007 
Norway Retrospective 
analysis of two 
birth cohorts 
Not specified <28 weeks 
≥28 weeks 
<1500g Hospital Patient records 
Seaton et al53  2011-
2014 
England Retrospective 
analysis of 
electronic 
health records 
2011: 5368  
2012: 5343  
2013: 5228  
2014: 5099 
24-31  NA Neonatal 
care 
UK National Neonatal Research 
Database 
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Stephens et 
al54  
2001-
2011 
Australia 
(New South 
Wales) 
Retrospective 
analysis of 
regional birth 
cohort 
24-27 weeks: 3659 
28-31 weeks: 7235 
32-33 weeks: 9007 
39-40 weeks: 
539,631 
24-27  
28-31  
32-33  
39-40  
NA Hospital Linked New South Wales 
Perinatal Data Collection, 
Admitted Patient Data Collection, 
and Registry of Births, Deaths and 
Marriages 
Thanh et al56  2004-
2010 
Canada 
(Alberta) 
Retrospective 
analysis of 
regional birth 
cohort 
<2,500g: 16,209 
≥2,500g: 189,586 
NA <2,500g 
≥2,500g 
Hospital, 
NICU 
Alberta 
Perinatal Health Program 
administrative databases 
van Baaren 
et al57  
2006-
2012 
Netherlands Retrospective 
analysis of one 
prospective 
cohort study 
and three 
randomised 
controlled 
trials 
4,552  
1090 singletons 
3462 multiples 
24–28  
28–32  
32–36 
≥37 
NA Hospital One prospective cohort study 
(APOSTEL I ) and three 
randomised controlled trials 
(APOSTEL II, AMPHIA and 
PROTWIN) 
Xu et al59  2003 USA 
(Michigan) 
Retrospective 
analysis of 
regional birth 
cohort 
<37 weeks: 9780  
≥37 weeks: 101,484  
≥20  NA Hospital Linked live birth certificate files, 
hospital discharge data and 
mortality data from the 
Michigan Department of 
Community Health and the 
National Center for Health 
Statistics 
NA, not applicable. 
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Appendix 4: Resource use and/or economic costs associated with the initial hospitalisation 
Study Currency Price date Cost per live birth (mean)  Cost per 
survivor (mean) 
Maternal 
cost per 
live birth 
(mean) 
Length of stay 
(days) per live 
birth (mean) 
Length of 
stay 
(days) per 
survivor 
(mean) 
Allen et al18  US $ Not specified NA 23 weeks: 
266,000±25,700 
NA NA 114±11 
 
  
 
24 weeks: 
239,900±34,450 
  
111±13 
 
  
 
25 weeks: 
208,550±54,550 
  
91±23 
Almond et al19  US $ 2006 94,000 for the three ounces prior to the 1500g 
threshold, falling to 85,000 at three ounces after the 
threshold 
NA NA 27.3 immediately 
prior to threshold; 
25.7 immediately 
after the threshold. 
NA 
Aly et al20  NA NA NA NA NA 33-34 weeks: 
10.7% ≤3 days 
89.3% > 3 days 
 
35-36 weeks: 
56.0% ≤3 days 
44.0% > 3 days 
 
33-36 weeks: 
42.7% ≤3 days 
57.3% > 3 days 
NA 
Barradas et al21  US $ 
 
Not specified Medicaid (Med); Commercial (Com); Self-pay (SP) NA NA Med; Com; SP NA 
   Preterm, low birthweight: 16,200; 15,300; 8,000   12.8; 11.9; 7.2  
   <1500g: 57,000; 61,100; 24,000   38.3; 39.4; 15.9  
   1,500–2,499g: 12,300; 12,600; 8,200   10.9; 11.1; 7.9  
   >2,500g: 4600; 4,500; 3300   4.6; 4.5; 3.9  
   No stated birthweight: 11,000; 10,300; 2600 
Term and normal birthweight: 1300; 1300; 1200 
  11.0; 10.5; 1.7 
2.4; 2.4; 2.3 
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Bird et al23  NA NA NA NA NA 34-36: 2.61   
37-42: 1.96 
NA 
Bulut et al24  NA NA NA NA NA 34-36: 7 
≥37: 4 
 
Cavallo et al25  € 2008 Hospital: 
≤30 weeks and/or ≤1500g: 20,502; Term: 907 
Societal: 
≤30 weeks and/or ≤1500g: 32,460; Term: 2640 
NA NA ≤30 weeks and/or 
≤1500g: 59.7 
37-42 weeks: 3.0 
NA 
Comert et al26  US $ NA 28-32 weeks: 2575 
33-37 weeks: 1525 
NA NA 28-32 weeks: 15.58 
33-37 weeks: 12.04 
NA 
Hall and 
Greenberg29 
US $ 2012 23 weeks: 599,000 NA 9000 NA NA 
 
 
 
24 weeks: 553,000 
 
9000 
  
 
 
 
25 weeks: 507,000 
 
9000 
  
 
 
 
26 weeks: 413,000 
 
8000 
  
 
 
 
27 weeks: 347,000 
 
8000 
  
 
 
 
28 weeks: 277,000 
 
8000 
  
 
 
 
29 weeks: 216,000 
 
8000 
  
 
 
 
30 weeks: 172,000 
 
8000 
  
 
 
 
31 weeks: 123,000 
 
7000 
  
 
 
 
32 weeks: 85,000 
 
6000 
  
 
 
 
33 weeks: 55,000 
 
5000 
  
 
 
 
34 weeks: 19,000 
 
4000 
  
 
 
 
35 weeks: 11,000 
 
4000 
  
 
 
 
36 weeks: 6000 
 
4000 
  
Hinchliffe et al31  NA NA NA NA NA  24 weeks: 
116*  
 
    
 25 weeks: 
107*  
 
    
 26 weeks: 
93*  
 
    
 27 weeks: 
76* 
45 
 
 
 
    
 28 weeks: 
65* 
Khan et al36  £ 2010-11 32-33 weeks: 
Postnatal: 2207.13; Neonatal: 9226.81; Transfer: 
61.64; Post-mortem: 22.97; Surgery: 51.34; 
Investigations: 58.72; Other: 194.66; Total: 
11,628.60 
NA NA NA NA 
 
  34-36 weeks: 
Postnatal: 1948.73; Neonatal: 2497.97; Transfer: 
12.24; Post-mortem: 2.52; Surgery: 46.13; 
Investigations: 20.5; Other: 81.40; Total: 4528.02 
    
 
  32-36 weeks: 
Postnatal: 1985.26; Neonatal: 3449.17; Transfer: 
19.23; Post-mortem: 5.41; Surgery: 46.86; 
Investigations: 25.91; Other: 97.41; Total: 5532.62 
    
 
  ≥37 weeks: 
Postnatal: 1708.54; Neonatal: 146.45; Transfer: 
0.02; Post-mortem: 1.86; Surgery: 0.81; 
Investigations: 6.76; Other: 9.45; Total: 1864.38 
    
Khashu et al37  NA NA NA NA NA 33-36 weeks: 5.92 
37-40 weeks: 2.38 
NA 
Korvenranta et al38  NA NA NA NA NA NA 22-23 
(weeks): 
136.7; 24-
25: 122.1; 
26-27: 
93.7; 28-
29: 67.4; 
30-31: 
47.6; >31: 
42.3 
Korvenranta et al40  € 2008 NA 23 (weeks): 
147,398 
24-25: 120,179 
26-27: 88,188 
28-29: 56,588 
NA NA 23 
(weeks): 
136.7 
24-25: 
122.1 
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30-31: 35,147 
All preterm: 
54,104 
Term: 1334 
26-27: 
94.4 
28-29: 
67.5 
30-31: 
48.0 
All 
preterm: 
64.4 
Term: 3.5 
Leone et al42  NA NA NA NA NA 34 weeks: 13.6 
35 weeks: 12.1 
36 weeks: 7.0 
Term: 5.2 
NA 
Lim et al43  Can $  Not specified Singletons:  
<28 weeks: 84,235 (singletons); 90,123 (multiples) 
28-31 weeks: 43,718 (singletons); 47,318 (multiples) 
32-33 weeks: 19,463 (singletons; 21,388 (multiples) 
34-36 weeks: 5047 (singletons); 6494 (multiples) 
Any preterm: 9233 (singletons); 12,479 (multiples) 
≥37 weeks: 1050 (singletons); 1871 (multiples) 
 
 
NA NA Singletons:  
<28 weeks: 83.1 
28-31 weeks: 42.6 
32-33 weeks: 21.2 
34-36 weeks: 5.8 
Any preterm: 10.0 
≥37 weeks: 2.1 
Multiples:  
<28 weeks: 91.0 
28-31 weeks: 46.0 
32-33 weeks: 23.5 
34-36 weeks: 8.0 
Any preterm: 13.8 
≥37 weeks: 3.5 
NA 
Lo et al44  US $ Not specified 24 weeks: 98,162 
25 weeks: 83,070 
26 weeks: 90,936 
27 weeks: 79,463 
28 weeks: 59,928 
29 weeks: 52,998 
30 weeks: 40,568 
31 weeks: 30,853 
NA NA NA NA 
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32 weeks: 22,612 
33 weeks: 16,597 
34 weeks: 9740 
35 weeks: 5015 
36 weeks: 2413 
37 weeks: 1469 
38 weeks: 1070 
39 weeks: 994 
40 weeks: 1017 
41 weeks: 1058 
42 weeks: 1072       
Mangham et al46  £ 2006 NA <28 weeks:  
Delivery: 1762 
Neonatal: 84,453 
<33 weeks: 
Delivery: 708 
Neonatal: 57,726 
<37 weeks: 
Delivery: 322 
Neonatal: 21,066 
NA NA NA 
McLaurin et al47  US $ Not specified 33-36 weeks: 26,054 
≥37 weeks: 2087 
NA 33-36 
weeks: 
6672 
≥37 
weeks: 
1943 
33-36 weeks: 8.8 
≥37 weeks: 2.2 
NA 
Meyers and 
Meyers48 
US $ Not specified <2500g: 23,382 
≥2500g: 5951 
NA NA <2,500g or <37 
weeks: 11.9 
Infants with an 
uncomplicated 
newborn stay: 2.3 
All other infants: 
4.2 
NA 
48 
 
Mistry et al49  £ 2005-6 Excluding ambulance transfer costs: 
Level 2 units: 12,344 
Level 3 unit: 17,861 
Including ambulance transfer costs: 
Level 2 units: 12,881 
Level 3 unit: 18,459 
NA NA Level 2 units: 29.8 
Level 3 unit: 29.4 
NA 
Nordermoen and 
Bratlid51 
€ Not specified <1500g: 
1997: 67,700 
2007: 75.300 
<1500g: 
1997: 130,100 
2007: 108,500 
<28 weeks: 
1997: 349,000 
2007: 429,500 
NA NA NA 
Seaton et al53  NA NA NA NA NA Intensive care:  
24 weeks: 33; 25: 30; 
26: 23; 27: 18; 28: 14; 
29: 10; 30: 6; 31: 4 
High dependency:  
24 weeks: 29; 25: 33; 
26: 29; 27: 25; 28: 19; 
29: 13; 30: 9; 31: 6 
Special care:  
24 weeks: 22; 25: 27; 
26: 30; 27: 31; 28: 33; 
29: 33; 30: 31; 31: 28 
NA 
Stephens et al54  US $ 2014 24-27: 180,515* 
28-31: 62,450* 
32-33: 23,455* 
39-40: 2995* 
NA NA 24-27: 87* 
28-31: 47*  
32-33: 25*  
39-40: 3* 
NA 
Thanh et al56  Can $ 2013 <2500g: 18,126 
≥2500g: 1657 
NA NA Hospital days: 
<2500g: 12.3 
≥2500g: 1.8 
NICU days: 
<2500g: 11.2 
≥2500g: 0.2 
NA 
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van Baaren et al57  € 2011 <24 weeks: 
Singletons: NA; multiples: 41,700 
24 weeks: 
Singletons: 88,052; multiples: 79,572 
25 weeks: 
Singletons: 83,774; multiples:141,598 
26 weeks: 
Singletons: 71,821; multiples: 169,100 
27 weeks: 
Singletons: 70,984; multiples: 169,571 
28 weeks: 
Singletons: 60,783; multiples: 135,084 
29 weeks: 
Singletons: 45,444; multiples: 102,048 
30 weeks: 
Singletons: 34,510; multiples: 66,013 
31 weeks: 
Singletons: 26,296; multiples: 44,405 
32 weeks: 
Singletons: 21,157; multiples: 33,991 
33 weeks: 
Singletons: 15,912; multiples: 30,129 
34 weeks: 
Singletons: 11,222; multiples: 21,457 
35 weeks: 
Singletons: 6492; multiples: 14,306 
36 weeks: 
Singletons: 2924; multiples: 8618 
≥37 weeks: 
Singletons: 1434; multiples: 5201 
NA NA NA NA 
Xu et al59  US $ 
 
2007 20 weeks: 11,397 
21 weeks: 11,703 
22 weeks: 25,367 
23 weeks: 48,908 
24 weeks: 99,477 
25 weeks: 82,296 
26 weeks: 103,980 
NA NA NA NA 
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27 weeks: 72,212 
28 weeks: 56,933 
29 weeks: 45,598 
30 weeks: 34,642 
31 weeks: 29,679 
32 weeks: 24,623 
33 weeks: 21,887 
34 weeks: 18,617 
35 weeks: 15,864 
36 weeks: 12,305 
≥37 weeks: 6368 
* Median value. NA, not applicable.                                                                   
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Appendix 5: Methods of studies reporting resource use and/or economic costs following initial hospital discharge 
Study Date 
of 
study 
popu-
lation 
Location Type of study Sample size Gestational 
age(s) 
(weeks) 
Birth 
weight 
(g) 
Type of resource 
inputs/costs 
Data sources Time 
frame 
Barradas 
et al21  
2009 USA Retrospective 
analysis of 
national  birth 
cohort  
4,167,000 (9.1% 
were preterm or 
low birthweight) 
<37 <2500 Hospital US Nationwide 
Inpatient Sample 
Database  
First 28 
days of life 
Berard et 
al22  
1997-
2000  
Canada 
(Quebec) 
Retrospective 
cohort study 
Term live births: 
33,879 
Late preterm live 
births: 2176 
33-36  
≥37 
NA Hospitalisation, 
physician visits, 
emergency 
department visits 
and prescriptions 
following initial 
hospitalisation 
Linkage of three 
Quebec 
administrative 
databases: Régie de 
l’Assurance Maladie 
du Québec, MED-
ECHO, Institut de la 
Statistique du 
Québec 
First 3 
years of 
life; 
first 2 years 
of life; and 
third year 
of life  
Bird et 
al23  
2001-
2005 
USA 
(Arkansas) 
Retrospective 
analysis of 
Medicaid 
claims 
database 
34-36 weeks: 5188  
37-42 weeks: 
15,303 
34 -36  
37– 42  
NA Hospital inpatient 
and outpatient care 
Arkansas Medicaid 
claims data linked to 
state birth certificate 
data  
First year 
of life 
Cavallo et 
al25  
2006 Italy Prospective 
cohort study 
Gestational age ≤30 
and/or birthweight 
≤1500: 150  
37-42 weeks: 145 
≤ 30  
37-42  
≤ 1500 Hospital 
readmissions, 
outpatient visits, 
general practitioner 
consultations, broader 
societal 
Parent questionnaires 
competed at 6 and 18 
months 
From initial 
hospital 
discharge 
to 18 
months 
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Corchia et 
al27  
2007-
2008 
Italy 
(Lazio) 
Retrospective 
cohort study 
90,545 of whom 
628 were VPT, 
6143 MLPT, 
29,219 ET and 
54,555 FT 
VPT: 24-31 
MLPT: 32-
36  
ET: 37-38 
FT: 39-41  
NA Emergency 
department visits 
and re-
hospitalisations 
Linkage between the 
regional Birth 
Certification Register, 
the regional Hospital 
Discharge Register 
and the regional 
Emergency 
Department Register 
Three years 
following 
initial 
hospital 
discharge 
Gareau et 
al28  
2009-
2013 
USA Retrospective 
cohort study 
1262 women 
involved in 
‘Centering 
Pregnancy’ group 
prenatal care and 
5066 receiving 
individual 
prenatal care 
Low risk 
women  
Low risk 
women  
Professional and 
inpatient Medicaid 
claims 
Medicaid data at a 
pilot programme in 
South Carolina 
First year 
postpartum 
Helle et 
al30  
2006-
2008 
Finland 
(Municipali
ties of 
Helsinki, 
Espoo, 
Vantaa) 
Prospective 
cohort study 
<32 weeks: 198  
32-33 weeks: 205 
34-36 weeks: 
1164  
37-38 weeks: 
4586   
39-41 weeks: 
21,812  
>41 weeks: 2005 
<32 
32-33 
34-36  
37-38 
39-41 
>41  
NA Specialized care, 
primary care, 
private health care, 
medications 
Linkage between 
national medical birth 
register and 
outpatient, inpatient, 
and primary care 
registers 
First 3 
years of life 
Hong et 
al32  
2000-
2004 
Australia 
(New South 
Wales) 
Retrospective 
cohort study 
<32 weeks: 2939 
survivors 
<32  NA Respiratory-related 
hospitalisation 
Linkage between 
New South Wales 
(NSW) Admitted 
Patient Data 
Collection and the 
NSW Registry of 
Births, Deaths and 
Marriages 
First 3 
years post 
initial 
hospital 
discharge 
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Hummer 
et al33  
2005-
2009 
Austria Econometric 
analysis of 
administrative 
data 
<1500g: 
119 (year 0-1) 
462 (years 2-5) 
1136 (years 6-14) 
425 (years 15-21) 
<2500g:  
854 (year 0-1) 
2957 (years 2-5) 
7926 (years 6-14) 
4856 (years 15-21) 
≥2500g:  
18,579 (year 0-1) 
70,328 (years 2-5) 
227,548 (years 6-14) 
134,739 (years 15-
21) 
NA <1500 
<2500 
≥2500 
Outpatient 
expenditures, 
medical attendance, 
drugs  
Administrative data 
from the Upper 
Austrian Sickness 
Fund and the 
Austrian birth 
register 
Stratified 
ages: 
year 0-1 
years 2-5 
years 6-14 
years 15-21 
Jacob et 
al34  
2011-
2012 
Germany Retrospective 
cohort study 
<28 weeks: 23 
29-36 weeks: 526 
≥37 weeks: 5,398 
<28 weeks 
29-36 weeks 
≥37 weeks 
NA Medication, 
hospital treatment, 
ambulatory 
treatment, and non-
medical remedies 
German health 
insurance 
company 
First 
3 years of 
life 
Johnston 
et al35  
1996-
1997  
Canada 
(Québec) 
Decision-
analytic model 
populated with 
data from 
administrative 
population-
based 
databases 
<28 weeks:  
1,828  
28–32 weeks: 
4,685  
33–36 weeks: 
20,795 
<28 weeks 
28-32 weeks 
33-36 weeks  
NA Direct medical, 
parental time off 
work 
Régie de l'assurance 
maladie du Québec 
(RAMQ) physician 
billing data from 
Québec, Canada 
linked to MED-
ÉCHO hospital 
discharge abstract 
databases 
First ten 
years of life 
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Khan et 
al36  
2009-
2010 
UK  
(East 
Midlands) 
Prospective 
cohort study 
32-33 weeks: 85 
34-36 weeks: 508 
32-36 weeks: 594 
≥37 weeks: 716 
32-33  
34-36  
32-36  
≥37 
NA Neonatal, other 
hospital, 
community care, 
medications, lost 
earnings, special 
equipment, 
adaptations 
Bespoke 
questionnaires 
designed for The 
Late and Moderate 
Preterm Birth Study 
(LAMBS) 
From initial 
hospital 
discharge 
to 24 
months  
Korvenra
nta et al38  
2000-
2003 
Finland Retrospective 
national 
register study 
22-23 weeks: 17  
24-25 weeks: 135  
26-27 weeks: 234  
28-29 weeks: 391  
30-31 weeks: 771  
>31 weeks: 248 
<32  
  
<1501 Hospital re-
hospitalisations and 
outpatient visits 
Finnish Medical 
Birth Register and 
Finnish Hospital 
Discharge Register 
First 3 
years of life 
Korvenra
nta et al39  
2001-
2002 
Finland Prospective 
cohort study 
<32 weeks: 901  
38–42 weeks: 368 
<32  
38–42  
<1501  Emergency 
outpatient, 
Nonemergency 
outpatient, 
Hospitalisations, 
Other physician visits, 
Physical therapy/ 
occupational therapy, 
Psychologist,  
Nurse practitioner,  
Speech therapist, 
Other 
Finnish Medical 
Birth Register and 
Finnish Hospital 
Discharge Register; 
parental 
questionnaires 
Fifth year 
of life 
55 
 
Korvenra
nta et al40  
2000-
2003 
Finland Retrospective 
national 
register study 
Preterm survivors:  
23 weeks: 17   
24-25 weeks: 135  
26-27 weeks: 231  
28-29 weeks: 385  
30-31 weeks: 756 
Preterm non-
survivors: 278  
Term: 200,609 
<32  
37–41 
 
<1501 Nonemergency 
outpatient visits, 
emergency 
outpatient visits, 
hospital 
readmissions 
Finnish Medical 
Birth Register and 
Finnish Hospital 
Discharge Register 
First 4 
years of life 
Kuzniewi
cz et al41  
2003-
2012 
USA 
(California) 
Retrospective 
cohort study 
31-33 weeks: 
3696  
34-36 weeks: 
19,494  
37-38 weeks: 
74,023  
39+ weeks: 
212,523 
31-33  
34-36  
37-38  
39+  
NA Hospital 
readmissions, 
emergency 
department visits 
Kaiser Permanente 
cohort, integrated 
health care delivery 
system, Northern 
California.  
30 days 
after initial 
hospital 
discharge 
Luu et 
al45  
2003-
2004 
Canada 
(Quebec) 
Prospective 
cohort study 
23–25 weeks : 49 
26–28 weeks: 205 
23–25 
26–28  
NA Inpatient hospital 
services, outpatient 
healthcare services, 
prescribed 
medication and 
assistive 
technology use 
Parental 
questionnaires 
completed as part of 
‘The Research 
Consortium on 
Children Born 
Extremely Preterm’ 
cohort, cross-checked 
against medical charts 
From 
neonatal 
discharge 
to 18 
months 
Mangham 
et al46 
2006 England 
and Wales 
Decision-
analytic model 
populated with 
data from 
administrative 
population-
based 
databases 
≤ 27 weeks: 3185 
28-31 weeks: 5575 
32-33 weeks: 6410 
34-36 weeks: 
32,812 
≥37 weeks: 621,618 
All NA Hospital inpatient, 
hospital outpatient, 
community health 
and social care, 
education services 
Secondary data from 
external cohorts and 
cross-sectional 
studies 
First 18 
years 
of life 
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McLaurin 
et al47  
2004 USA Retrospective 
analysis of 
insurance 
database 
33-36 weeks: 1683  
≥37 weeks: 33,745 
33–36 
≥37 
NA Inpatient 
hospitalisations, 
well-infant 
physician office 
visits, outpatient 
hospital services, 
home health/private 
nurse, acute care 
physician office 
visits, prescription 
drugs, other 
professional 
MedStat MarketScan 
Commercial Claims 
and Encounters 
database 
First year 
of life 
Mourani 
et al50  
2001-
2007 
USA Follow-up of 
randomised 
controlled trial 
Year 1: 512; years 
1-2: 455; years 2-
3: 412; years 3-
4.5: 282 
≤34 weeks 
with 
requirement 
for 
mechanical 
ventilation at 
birth 
500-1250 Hospital, outpatient Prophylactic inhaled 
nitric oxide trial 
(iNO) with follow-up 
through parental 
interviews and 
assessment of 
medical bills 
First 4.5 
years of life 
Petrou et 
al52  
1995 UK and 
Republic of 
Ireland 
Prospective 
cohort study 
20-25 weeks: 190,  
Mainstream 
school 
classmates: 141 
20-25 
Classmates 
NA Hospital inpatient 
care, outpatient and 
day care, 
community health 
and social care, 
drugs/medications, 
education services 
Parental 
questionnaires as part 
of EPICure whole 
population cohort 
study  
The 11th 
year of life 
Stephens 
et al54  
2001-
2011 
Australia 
(New South 
Wales) 
Retrospective 
analysis of 
regional birth 
cohort 
24-27 weeks: 3659 
28-31 weeks: 7235 
32-33 weeks: 9007 
39-40 weeks: 
539,631 
24-27  
28-31  
32-33  
39-40  
NA Hospital Linked New South 
Wales Perinatal Data 
Collection, Admitted 
Patient Data 
Collection, and 
Registry of Births, 
Deaths and 
Marriages 
First 6 
years of life 
57 
 
Stephens 
et al55  
2001-
2005 
Australia 
(New South 
Wales) 
Retrospective 
analysis of 
regional birth 
cohort 
33-34 weeks: 3878 
35-36 weeks: 
12,665 
37-38 weeks: 
80,478 
39-40 weeks: 
218,254 
≥41 weeks: 
77,689 
33-34  
35-36  
37-38  
39-40  
≥41 
NA Hospital Linked New South 
Wales Perinatal Data 
Collection, Admitted 
Patient Data 
Collection, and 
Registry of Births, 
Deaths and 
Marriages 
Between 1 
and 6 years 
of age 
Thanh et 
al56  
2004-
2010 
Canada 
(Alberta) 
Retrospective 
analysis of 
regional birth 
cohort 
<2500g: 16,209 
≥2500g: 189,586 
NA <2500g 
≥2500g 
Hospital inpatient 
and outpatient 
services, 
practitioner 
services 
Alberta 
Perinatal Health 
Program 
administrative 
databases 
First year 
of life 
Westrupp 
et al58  
2004-
13 
Australia Prospective 
cohort studies 
Birth cohort:  
Moderate-to-high 
risk: 297 
Mild risk: 442  
No perinatal risk: 
3,973  
Kindergarten 
cohort:  
Moderate-to-high 
risk: 361 
Mild risk: 465 
No perinatal risk: 
3,629 
 
Moderate-to-
high risk: 
<32 
Mild risk: 
32–36 
No perinatal 
risk: ≥37 
Moderate-
to-high 
risk: 
<1500g 
Mild risk: 
1500–
2499g 
No 
perinatal 
risk: 
≥2500g 
 
Community-based 
health care, 
prescription 
medications 
and total Medicare 
combined 
costs 
Longitudinal Study 
of Australian 
Children cohort 
studies with 
Medicare data 
linkage 
Up to first 
9 years of 
age 
Young et 
al60  
2000-
2010 
USA (Utah 
and Idaho) 
Retrospective 
analysis of 
insurance 
database 
34-36 weeks: 
19,081 
37-38 weeks: 
94,178 
39-42 weeks: 
180,144  
34-36 
37-38 
39-42  
NA Hospital Intermountain 
Healthcare 
Enterprise Data 
Warehouse 
Within 28 
days of 
initial 
discharge 
58 
 
Notes: BPD, bronchopulmonary dysplasia; HO, home oxygen; EPT, extremely preterm; VPT, very preterm; MPT, moderately preterm; MLPT, moderate to late preterm; LMPT, late 
and moderate preterm; LPT, late preterm; PT, preterm; ET: early term; FT, full term; LT, late term; VLBW, very low birthweight; LBW, low birthweight; NBW, normal birth weight; 
NA, not applicable. 
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Appendix 6: Resource use and/or economic costs following the initial hospital discharge 
Study Currency (price date) Total cost per child 
including initial 
hospitalisation 
(mean)  
Total cost per 
survivor 
including initial 
hospitalisation 
(mean) 
Costs following initial hospital discharge 
(mean) (unless otherwise stated) 
Rehospitalisation length of 
stay (mean days) (unless 
otherwise stated) 
Barradas 
et al21  
US $ (2015 prices)± Medicaid: 16,200; 
Commercial: 15,300; 
Self-pay: 8000 
NA Medicaid: 12,800; Commercial: 12,400; Self-
pay: 6400 
Medicaid: 7.4; Commercial: 
6.8; Self-pay: 4.6 
Berard et 
al22  
Can $ (2003 prices) 
(1Can$, 2003 prices = 
1.04US$, 2015 prices) 
NA NA LPT: 
Re-hospitalisation: 1727 (years 0-3), 1530 
(years 0-2), 212 (years 2-3).  
Physician visits: 977 (0-3), 756 (0-2), 221 (2-
3).  
Emergency department visits: 2 (0-3), 1 (0-2), 
1 (2-3).  
Prescriptions: 388 (0-3), 282 (0-2), 106 (2-3) 
NA 
 
  
 
Term: 
Re-hospitalisation: 628 (years 0-3), 527 (years 
0-2), 102 (years 2-3).  
Physician visits: 766 (0-3), 575 (0-2), 191 (2-
3).  
Emergency department visits: 1 (0-3), 1 (0-2), 
1 (2-3).  
Prescriptions: 257 (0-3), 182 (0-2), 75 (2-3) 
 
Bird et 
al23  
US $ (2009 prices) ± 
(1US$, 2009 prices = 
1.10US$, 2015 prices) 
NA Inpatient: 
34-36: 3027 
37-42: 2183 
Outpatient: 
34-36: 1560 
37-42: 1316 
Total health 
care: 
34-36: 4541 
37-42: 3472 
NA 34-36 (survivors): 0.65  
37-42 (survivors): 0.48 
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Cavallo et 
al25  
€ (2008 prices) 
(1€, 2008 prices = 
1.45US$, 2015 prices) 
NA NA ≤30 weeks and/or ≤1500g: 
From discharge to six months:   
Total public health system cost: 1433  
Total societal cost: 13,382 
From six months to 18 months:  
Total public health system cost: 820  
Total societal cost: 12,257 
NA 
 
  
 
Term: 
From discharge to six months:   
Total public health system cost: 565  
Total societal cost: 12,368 
From six months to 18 months:  
Total public health system cost: 391  
Total societal cost: 920 
 
Corchia et 
al27  
NA NA NA NA 1st year rehospitalisation rate: 
VPT: 24.8%; MLPT: 16.0%; 
ET:15.7%; FT: 12.6% 
2nd year rehospitalisation rate: 
VPT: 9.8%; MLPT: 8.4%; 
ET: 8.9%; FT: 7.5% 
3rd year rehospitalisation rate: 
VPT: 9.7%; MLPT: 5.3%; 
ET: 5.4%; FT: 4.9% 
Gareau et 
al28  
US $ (2016 prices) NA NA Estimated savings from avoiding poor 
outcomes: 
Preterm birth: 22,667 
Low birthweight: 29,627 
NA 
Helle  
et al30  
€ (2011 prices) 
(1€, 2011 prices = 
1.18US$, 2015 prices) 
NA <32: 45,107* 1926* (Year 2); 1116* (Year 3) NA 
  32-33: 19,872* 995* (Year 2); 517* (Year 3) 
 
  34-36: 5621* 870* (Year 2); 551* (Year 3) 
 
 37-38: 2987* 788* (Year 2); 482* (Year 3) 
 
 
  39-41: 2700* 742* (Year 2); 452* (Year 3) 
 
 
  >41: 2679* 748* (Year 2); 457* (Year 3) 
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Hong et 
al32  
NA  NA NA Mean: No BPD: 1,349, BPD/No-HO: 948, 
BPD/HO: 897 
Amongst survivors:  
All: 4.42* 
No BPD: 3.67: 
BPD/No HO: 6.48 
BPD/HO: 8.54 
Hummer 
et al33  
€ (2009 prices) 
(1€, 2009 prices = 
1.35US$, 2015 prices) 
NA NA <1500g: 
Outpatient expenditures:  
1173.76 (year 0-1); 289.12 (years 2-5);  
319.83 (years 6-14); 218.17 (years 15-21) 
Medical attendance:  
207.03 (year 0-1); 208.39 (years 2-5);  
256.07 (years 6-14); 176.83 (years 15-21) 
Medical drugs taken: 
966.73 (year 0-1); 80.73 (years 2-5); 
63.75 (years 6-14); 41.34 (years 15-21) 
<1500g:  
1.21 (years 2-5) 
0.72 (years 6-14) 
1.19 (years 15-21) 
  
 
 
<2500g: 
Outpatient expenditures:  
320.82 (year 0-1); 233.75 (years 2-5);  
219.19 (years 6-14); 202.38 (years 15-21) 
Medical attendance:   
232.56 (year 0-1); 191.98 (years 2-5); 
180.64 (years 6-14); 158.86 (years 15-21) 
Medical drugs taken: 
88.25 (year 0-1); 41.77 (years 2-5); 
38.55 (years 6-14); 43.52 (years 15-21) 
<2500g: 
0.81 (years 2-5) 
0.67 (years 6-14) 
0.99 (years 15-21) 
  
 
 
≥2500g: 
Outpatient expenditures:  
227.75 (year 0-1); 198.97 (years 2-5);  
194.96 (years 6-14); 184.41 (years 15-21) 
Medical attendance:   
 202.37 (year 0-1); 167.89 (years 2-5); 
 162.94 (years 6-14);  147.56 (years 15-21) 
Medical drugs taken: 
 25.38 (year 0-1);  31.09 (years 2-5); 
 32.01 (years 6-14); 36.85 (years 15-21) 
≥2500g: 
0.54 (years 2-5) 
0.44 (years 6-14) 
0.73 (years 15-21) 
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Jacob et 
al34  
€ (2016 prices)± <28 weeks: 
74,009 (year 1)  
NA <28 weeks:  
5341 (year 2); 3390 (year 3) 
NA 
 
 29-36 weeks: 
8565 (year 1)  
 
29-36 weeks: 
1603 (year 2); 1053 (year 3) 
 
  
≥37 weeks: 
1590 (year 1)  
 
≥37 weeks: 
902 (year 2); 756(year 3) 
 
Johnston 
et al35  
Can $ (2012 prices) 
(1Can$, 2012 prices = 
0.84US$, 2015 prices) 
<28 weeks: 
67,467 
NA <28 weeks: 
9280 (Medical from discharge to year 2)  
1374 (Medical, years 2-4),  
875 (Indirect, years 2-4),  
1059 (Medical, years 5-10),  
782 (Indirect, years 5-10) 
<28 weeks: 
17.45 (Discharge-year 2)  
0.89 (year 2-3)  
0.65 (year 3-4)  
0.42 (year 4-5)  
0.50 (year 5-6)  
0.32 (year 6-7)  
0.45 (year 7-8)  
0.24 (year 8-9)  
0.04 (year 9-10) 
  
28-32 weeks: 
54,554 
 
28-32 weeks: 
6573 (Medical from discharge to year 2)  
1936 (Medical, years 2-4),  
1136 (Indirect, years 2-4),  
1077 (Medical, years 5-10),  
912 (Indirect, years 5-10) 
28-32 weeks: 
8.75 (Discharge-year 2)  
1.60 (year 2-3)  
0.50 (year 3-4)  
0.35 (year 4-5)  
0.39 (year 5-6)  
0.24 (year 6-7)  
0.22 (year 7-8)  
0.19 (year 8-9)  
0.09 (year 9-10) 
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33-36 weeks: 
10,010 
 
33-36 weeks: 
2228 (Medical from discharge to year 2) 
1015 (Medical, years 2-4),  
805 (Indirect, years 2-4),  
814 (Medical, years 5-10),  
779 (Indirect, years 5-10) 
33-36 weeks: 
2.40 (Discharge-year 2)  
0.40 (year 2-3)  
0.26 (year 3-4)  
0.20 (year 4-5)  
0.16 (year 5-6)  
0.20 (year 6-7)  
0.17 (year 7-8)  
0.10 (year 8-9)  
0.10 (year 9-10) 
Khan et 
al36  
UK£ (2010-11 prices) 
(1UK£, 2011 prices = 
1.51US$, 2015 prices) 
32-33 weeks: 
Neonatal care: 
9387.69; Other 
hospital care: 
1411.65; 
Community care: 
960.22; 
Medications: 13.14; 
Lost earnings: 
252.87; Special 
equipment: 7.05; 
Adaptations: 4.24 
NA NA NA 
 
 34-36 weeks: 
Neonatal care: 
2827.01; Other 
hospital care: 
1642.21; 
Community care: 
1059.32; 
Medications: 7.15; 
Lost earnings: 
255.95; Special 
equipment: 4.87; 
Adaptations: 26.97 
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 32-36 weeks:  
Neonatal care: 
3765.83; Other 
hospital care: 
1069.22; 
Community care: 
1045.14; 
Medications: 8.01; 
Lost earnings: 
255.51; Special 
equipment: 5.18; 
Adaptations: 23.72 
 
 
 
 
 ≥37 weeks: 
Neonatal care: 
172.66; Other 
hospital care; 
673.76, Community 
care: 1005.24; 
Medications: 7.99; 
Lost earnings: 
155.86 Special 
equipment: 3.32; 
Adaptations: 36.70  
 
 
 
Korvenra
nta et al38  
NA NA NA NA Rehospitalisation rate (years 
1, 2 and 3):  
22-23 weeks: 76.5%, 47.1%, 
52.9% 
24-25 weeks: 65.9, 42.2%, 
37.8% 
26-27 weeks: 60.7%, 38.5%, 
26.1% 
28-29 weeks: 53.2%, 30.4%, 
19.7% 
30-31 weeks: 43.2%, 20.6%, 
17.1% 
>31 weeks: 40.7%, 27.8%, 
18.5% 
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All: 49.3%, 28.0%, 20.9% 
 
Mean outpatient visits (years 
1, 2 and 3):  
22-23 weeks: 10.5, 9.2, 6.9 
24-25 weeks: 10.5, 9.0, 6.0 
26-27 weeks: 9.8, 6.7, 4.5 
28-29 weeks: 9.7, 5.3, 3.1 
30-31 weeks: 7.4, 3.4, 2.0 
>31 weeks: 6.8, 4.1, 2.5 
All: 8.4, 4.8, 3.0 
Korvenrant
a et al39  
€ (2008 prices) 
(1€, 2008 prices = 
1.23US$, 2015 prices) 
NA NA VPT with morbidities: 3265 
VPT without morbidities: 1023 
Term: 749 
23 weeks: 3.0; 24-25: 0.3; 26-
27: 0.4; 28-29: 0.1; 30-31: 
0.2; Term: 0.1  
Korvenrant
a et al40  
€ (2008 prices) 
(1€, 2008 prices = 
1.23US$, 2015 prices) 
NA 23 weeks: 
175,490 
24-25: 143,570 
26-27: 105,631 
28-29: 72,366 
30-31: 45,714 
All: 68,073 
Term: 4580 
Nonemergency outpatient visits (survivors):  
23 weeks: 11,156 
24-25: 10,657 
26-27: 8306 
28-29: 7381 
30-31: 4797 
All: 6411 
Term: 720 
 
Emergency outpatient visits (survivors):  
23 weeks: 1183 
24-25: 1347 
26-27: 1367 
28-29: 926 
30-31: 699 
All: 900 
Term: 251 
 
Hospital readmissions (survivors):  
23 weeks: 15,753 
24-25: 10,753 
26-27: 7770 
23 week (survivors): 14.6 
24-25 (survivors): 12.1 
26-27 (survivors): 8.6 
28-29 (survivors): 8.2 
30-31 (survivors): 5.7  
All (survivors): 7.2  
Term (survivors): 2.0 
 
66 
 
28-29: 7661 
30-31: 5226 
All: 6675 
Term: 2275 
Kuzniewic
z et al41  
NA 
 
NA NA NA Rehospitalisation rate:  
4.2% (31 weeks); 2.9% (32); 
2.4% (33); 3.8% (34); 8.4% 
(35); 9.0% (36); 9.8% (37); 
5.4% (38); 3.8% (39); 3.1% 
(40); 2.5% (41); 1.9% (42) 
 
Emergency department visit 
rate:  
6.9% (31 weeks); 4.7% (32); 
5.3% (33); 4.7% (34); 4.6% 
(35); 4.6% (36); 4.2% (37); 
4.8% (38); 3.9% (39); 3.9% 
(40); 4.0% (41); 3.0% (42) 
Luu et al45  NA NA NA NA Hospital days (including 
neonatal admission): 
23-25 weeks: 124* 
26-28 weeks: 88* 
 
Long-term rehabilitation care: 
23-25 weeks: 29% rate 
26-28 weeks: 17% rate 
 
Regular prescribed 
medications: 
23-25 weeks: 38% rate 
26-28 weeks: 28% rate 
 
Any assistive devices: 
23-25 weeks: 59% rate 
26-28 weeks: 33% rate 
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Mangham 
et al46  
UK£ (2006 prices) 
(1UK£, 2006 prices = 
1.72US$, 2015 prices) 
 
NA Total 
incremental 
public sector 
cost vs term:  
<28 weeks: 
94,740 
<33 weeks: 
61,781 
<37 weeks: 
22,885 
<28 weeks (incremental cost vs term): 
Hospital outpatient: 1589; community health 
and social care: 1621; education: 3978 
<33 weeks (incremental cost vs term): 
Hospital outpatient: 802; community health 
and social care: 552; education: 1463 
<33 weeks (incremental cost vs term): 
Hospital outpatient: 553; community health 
and social care: 182; education: 494 
NA 
McLaurin 
et al47  
US $ (2008 prices)± 
(1US$, 2008 prices = 
1.11US$, 2015 prices) 
33-36 weeks: 38,301 
≥37 weeks: 6156 
NA 33-36 weeks: 12,247 
≥37 weeks: 4069 
33-36 weeks: 4.5 
≥37 weeks: 3.4 
 
Mourani 
et al50  
US $  (2012 prices) 
(1US$, 2012 prices = 
1.04US$, 2015 prices) 
NA NA Year 1: 
Children without readmissions: 9600* 
Children readmitted only to ward: 30,200* 
Children with ≥1 ICU readmission: 69,700* 
Year 2: 
Children without readmissions: 16,700* 
Children readmitted only to ward: 36,200* 
Children with ≥1 ICU readmission: 109,600* 
Year 3: 
Children without readmissions: 19,100* 
Children readmitted only to ward: 43,100* 
Children with ≥1 ICU readmission: 116,000* 
Year 4: 
Children without readmissions: 19,400* 
Children readmitted only to ward: 53,200* 
Children with ≥1 ICU  
readmission: 111,800* 
ICU days:  
Years 0-1: 11.1 
Years 1-2: 8.0 
Years 2-3: 6.1 
Years 3-4.5: 5.7 
Days of mechanical 
ventilation:  
Years 0-1: 9.3 
Years 1-2: 8.3 
Years 2-3: 6.6 
Years 3-4.5: 5.1 
Petrou et 
al52  
£ (2006-7 prices) 
(1UK£, 2007 prices = 
1.67US$, 2015 prices) 
 
NA NA ≤25 weeks: 
Hospital inpatient care: 345.9  
Hospital outpatient and day care: 158.0 
Community health and social care: 617.0 
Drugs/medications: 23.7 
Education services: 5339.2 
NA 
68 
 
Total public sector: 6483.9 
Classmates: 
Hospital inpatient care: 48.4 
Hospital outpatient and day care: 50.2 
Community health and social care: 273.5 
Drugs/medications: 11.7 
Education services: 3623.0 
Total public sector: 4007.3 
Stephens 
et al54  
US $ (2014 prices) 
(1US$, 2014 prices = 
1.01US$, 2015 prices) 
NA NA By 2 months of age: 
24-27: 26,800 
28-31: 9850 
32-33: 6890 
39-40: 4980   
 
 
Readmission rates: 
 
Within 30 days of initial 
discharge:  
24-27: 30.7% 
28-31: 19.9% 
32-33: 10.1% 
39-40: 3.4% 
Year 0-1: 
24-27: 62.1% 
28-31: 47.7% 
32-33: 36.2% 
39-40: 16.8% 
Year 1-2: 
24-27: 36.0% 
28-31: 25.3% 
32-33: 21.1% 
39-40: 13.3% 
Year 2-3: 
24-27: 28.4% 
28-31: 18.3% 
32-33: 16.0% 
39-40: 9.8% 
Year 3-4: 
24-27: 19.3% 
28-31: 15.7% 
32-33: 13.2% 
39-40: 8.7% 
Year 4-5: 
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24-27: 16.8% 
28-31: 13.3% 
32-33: 11.5% 
39-40: 8.1% 
Year 5-6: 
24-27: 14.8% 
28-31: 11.0% 
32-33: 10.0% 
39-40: 7.0% 
Stephens et 
al55  
Aus $ (2013 prices) 
(1Aus$, 2013 prices = 
0.69US$, 2015 prices) 
NA NA Cost per readmission: 
33-34 weeks: 2645 
35-36 weeks: 2651 
37–38 weeks: 2610 
39–40 weeks: 2591 
≥41 weeks: 2576 
Odds of readmission: 
33-34 weeks:  1.39 
35-36 weeks: 1.19 
37–38 weeks: 1.10 
39–40 weeks: 1.00 (Referent) 
≥41 weeks: 0.98 
Thanh et 
al56  
Can $ (2013 prices) 
(1Can$, 2013 prices = 
0.83US$, 2015 prices) 
<2,500g: 33,096 
≥2,500g: 3,942 
NA Inpatient services: 
<2500g: 11,834 
≥2500g: 1161 
Outpatient visits: 
<2500g: 1297 
≥2500g: 424 
Practitioner services: 
<2500g: 1858 
≥2500g: 701 
Hospital days: 
<2,500g: 7.4 
≥2,500g: 0.4 
NICU days: 
<2,500g: 6.0 
≥2,500g: 0.1 
 
Westrupp 
et al58  
Aus $ (2011 prices) 
(1Aus$, 2011 prices = 
0.70US$, 2015 prices) 
 
NA 
 
NA Birth cohort (first six years):  
Moderate-to-high risk:  
- Community health care: 2242 
- Prescribed medications: 162 
- Total Medicare: 2405 
Mild risk:  
- Community health care: 2284 
- Prescribed medications: 197 
- Total Medicare: 2481 
No perinatal risk:  
- Community health care: 1977 
- Prescribed medications: 111 
NA 
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- Total Medicare: 2088 
 
Kindergarten cohort (first six years):  
Moderate-to-high risk:  
- Community health care: 1468 
- Prescribed medications: 257 
- Total Medicare: 1725 
Mild risk:  
- Community health care: 1366 
- Prescribed medications: 179 
- Total Medicare: 1545 
No perinatal risk:  
- Community health care: 1208 
- Prescribed medications: 111 
- Total Medicare: 1319 
Young et 
al60  
NA 
 
NA NA NA Readmission rate per 1,000 
newborns:  
34-36 weeks: 34.6 
37-38 weeks: 20.6 
39-42 weeks: 14.8 
Notes: OHs, other hospitalisations; GPC, General Practitioner consultation; SVs, specialist visits; OSVs, other specialist visits; LATs, laboratory tests; ITs, imaging tests; RT, 
rehabilitation therapy; PS, psychological support; HAs, hospital admissions; PT/OT, Physical Therapy/Occupational Therapy; EAD, early Discharge; LAD, late Discharge; ICU, 
Intensive Care Unit; NICU, Neonatal Intensive Care Unit; BPD, bronchopulmonary dysplasia; HO, home oxygen; LOS, length of stay; EPT, extremely preterm; VPT, very preterm; 
MPT, moderately preterm; MLPT, moderate to late preterm; LMPT, late and moderate preterm; LPT, late preterm; PT, preterm; ET, early term; FT, full term; VLBW, very low 
birthweight; LBW, low birthweight; NBW, normal birth weight; NA, not applicable; BPD, bronchopulmonary dysplasia; HO, home oxygen. 
± As currency price dates not reported, it was assumed that the costs used in the valuation process applied to the financial year prior to study publication.  
 Cost conversion rates reflecting relevant country-specific Gross Domestic Product deflator indices and purchasing power parities supplied by the OECD. These rates vary across 
individual countries using the same currency such as the €.17 * Number expressed as median.
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